By observing the growth rate of subcutaneous tumors, we found that tumor growth was significantly accelerated in the group with AEBP1 overexpression (Figure 6(a)), while the growth of tumors in the group with AEBP1 silencing was significantly slowed down (Figure 6(b)). Here, AEBP1 is linked to neoplasm.